期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
米曲霉酸性蛋白酶基因在毕赤酵母中的异源表达及酶学性质 被引量:12
1
作者 岳晓平 陈朋 +5 位作者 朱玥明 曾艳 刘汉民 刘红彦 王敏 孙媛霞 《生物工程学报》 CAS CSCD 北大核心 2019年第3期415-424,共10页
酸性蛋白酶作为一类重要的天冬氨酸蛋白酶,被广泛应用于食品、医药和皮革等领域。为推动酸性蛋白酶的研究及应用,通过对发酵豆制品样品进行宏基因组测序,从中获得米曲霉酸性蛋白酶基因pepA,在毕赤酵母GS115中进行异源表达,并对重组酶Pep... 酸性蛋白酶作为一类重要的天冬氨酸蛋白酶,被广泛应用于食品、医药和皮革等领域。为推动酸性蛋白酶的研究及应用,通过对发酵豆制品样品进行宏基因组测序,从中获得米曲霉酸性蛋白酶基因pepA,在毕赤酵母GS115中进行异源表达,并对重组酶PepA进行酶学性质分析。结果显示毕赤酵母发酵上清液中酸性蛋白酶的活性为50.62 U/mL。SDS-PAGE验证PepA的分子量约为50 kDa,且发酵上清液几乎无杂蛋白。PepA的最适pH值为4.5,最适温度为50℃,Mn^(2+)和Cu^(2+)对其具有激活作用,而Fe^(3+)、Fe^(2+)与Ca^(2+)则具有抑制作用。上述研究结果可为米曲霉酸性蛋白酶的异源表达及其相关工业应用提供指导。 展开更多
关键词 米曲霉 酸性蛋白酶 毕赤酵母 异源表达 酶学性质
原文传递
Exosomal let-7a-5p derived from human umbilical cord mesenchymal stem cells alleviates coxsackievirus B3-induced cardiomyocyte ferroptosis via the SMAD2/ZFP36 signal axis 被引量:2
2
作者 Xin LI Yanan HU +3 位作者 Yueting WU Zuocheng YANG Yang liu hanmin liu 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2024年第5期422-437,共16页
Viral myocarditis(VMC)is one of the most common acquired heart diseases in children and teenagers.However,its pathogenesis is still unclear,and effective treatments are lacking.This study aimed to investigate the regu... Viral myocarditis(VMC)is one of the most common acquired heart diseases in children and teenagers.However,its pathogenesis is still unclear,and effective treatments are lacking.This study aimed to investigate the regulatory pathway by which exosomes alleviate ferroptosis in cardiomyocytes(CMCs)induced by coxsackievirus B3(CVB3).CVB3 was utilized for inducing the VMC mouse model and cellular model.Cardiac echocardiography,left ventricular ejection fraction(LVEF),and left ventricular fractional shortening(LVFS)were implemented to assess the cardiac function.In CVB3-induced VMC mice,cardiac insufficiency was observed,as well as the altered levels of ferroptosis-related indicators(glutathione) peroxidase 4(GPX4),glutathione(GSH),and malondialdehyde(MDA).However,exosomes derived from human umbilical cord mesenchymal stem cells(hucMSCs-exo)could restore the changes caused by CVB3 stimulation.Let-7a-5p was enriched in hucMSCs-exo,and the inhibitory ffect of hucMSCs-exoa-ie-pmimo on CVB3-induced ferroptosis was higher than that of hucMSCs-exommie N(NC:negative control).Mothers against decapentaplegic homolog 2(SMAD2)increased in the VMC group,while the expression of zinc-finger protein 36(ZFP36)decreased.Let-7a-5p was confirmed to interact with SMAD2 messenger RNA(mRNA),and the SMAD2 protein interacted directly with the ZFP36 protein.Silencing SMAD2 and overexpressing ZFP36 inhibited the expression of ferroptosis-related indicators.Meanwhile,the levels of GPX4,solute carrier family 7,member 11(SLC7A11),and GSH were lower in the SMAD2 overexpression plasmid(oe-SMAD2)+let-7a-5p mimic group than in the oe-NC+let-7a-5p mimic group,while those of MDA,reactive oxygen species(ROS),and Fe^(2+)increased.In conclusion,these data showed that ferroptosis could be regulated by mediating SMAD2 expression.Exo-let-7a-5p derived from hucMSCs could mediate SMAD2 to promote the expression of ZFP36,which further inhibited the ferroptosis of CMCs to alleviate CVB3-induced VMC. 展开更多
关键词 Exosome Let-7a-5p Mothers against decapentaplegic homolog 2(SMAD2) Coxsackievirus B3(CVB3) Ferroptosis
原文传递
Transplacental digoxin treatment for fetal supraventricular arrhythmias:Insights from Chinese fetuses
3
作者 Chuan Wang Li Zhao +9 位作者 Shuran Shao Haiyan Yu Shu Zhou Yifei Li Qi Zhu Xiaoliang liu Hongyu Duan hanmin liu Yimin Hua Kaiyu Zhou 《Chinese Medical Journal》 2025年第12期1499-1501,共3页
To the Editor:Transplacental digoxin therapy has been proven effective in converting fetal supraventricular arrhythmia(SVA)to sinus rhythm or achieving ventricular rate control,significantly improving fetal intrauteri... To the Editor:Transplacental digoxin therapy has been proven effective in converting fetal supraventricular arrhythmia(SVA)to sinus rhythm or achieving ventricular rate control,significantly improving fetal intrauterine outcomes.[1–3]However,limited data exist from large patient populations in China.Additionally,concerns remain regarding the relatively high non-response and intrauterine relapse rates during prenatal digoxin treatment.[4,5]Studies exploring the underlying risk factors for digoxin non-response and intrauterine relapse are limited.Therefore,this study aimed to analyze the Chinese data on outcomes and follow-up of fetal SVA treated with prenatal digoxin monotherapy and investigate risk factors associated with unresponsiveness and intrauterine relapse after transplacental digoxin treatment. 展开更多
关键词 improving fetal intrauterine outcomes howeverlimited digoxin therapy fetal supraventricular arrhythmia sinus rhythm achieving ventricular rate controlsignificantly transplacental digoxin therapy ventricular rate control intrauterine outcomes
原文传递
基质金属蛋白酶在儿童哮喘发生机制中作用的研究现状
4
作者 刘琴 刘瀚旻 谢亮 《中华妇幼临床医学杂志(电子版)》 CAS 2024年第5期564-568,共5页
儿童哮喘(childhood asthma)是一种常见儿童慢性气道炎症性疾病,临床表现为反复出现的喘息、呼吸急促和咳嗽。儿童哮喘的病理机制包括气管炎症、气道高反应性(AHR)和气道重塑(AR),可导致患儿气流受限和呼吸困难。儿童哮喘的病因复杂,涉... 儿童哮喘(childhood asthma)是一种常见儿童慢性气道炎症性疾病,临床表现为反复出现的喘息、呼吸急促和咳嗽。儿童哮喘的病理机制包括气管炎症、气道高反应性(AHR)和气道重塑(AR),可导致患儿气流受限和呼吸困难。儿童哮喘的病因复杂,涉及多种遗传和环境因素,可导致患儿气管对多种刺激因子表现出异常敏感性。近年研究表明,基质金属蛋白酶(MMP)在儿童哮喘病程中起着重要作用。MMP可通过调控细胞外基质(ECM)降解,促进炎症细胞迁移和气管结构改变,从而影响哮喘病情发展。目前,以MMP为靶点的儿童哮喘治疗方法,已在临床和临床前研究中显示出积极的治疗疗效。未来通过深入研究MMP在儿童哮喘中的复杂调控机制,有望精准开发更为有效的治疗药物,从而提高哮喘患儿生活质量,并为其他慢性气管疾病的治疗提供借鉴。笔者拟就MMP对儿童哮喘发生的作用机制及MMP对哮喘患儿分子靶向治疗应用的最新研究现状进行阐述。 展开更多
关键词 哮喘 基质金属蛋白酶类 支气管高反应性 气道重塑 细胞外基质蛋白质类 分子靶向治疗 儿童
原文传递
National Perinatal Prevalence of Selected Major Birth Defects--China,2010−2018 被引量:2
5
作者 Wenli Xu Changfei Deng +9 位作者 Wenyan Li Ke Wang Jing Tao Yuyang Gao Xiaohong Li Yanping Wang Juan Liang Jun Zhu hanmin liu Li Dai 《China CDC weekly》 2020年第37期711-717,共7页
Introduction:An estimated of 900,000 infants are born with birth defects each year in China causing a substantial disease burden.This study aimed to depict the epidemiological patterns of selected major birth defects ... Introduction:An estimated of 900,000 infants are born with birth defects each year in China causing a substantial disease burden.This study aimed to depict the epidemiological patterns of selected major birth defects in Chinese perinatal births and provide important baseline data for future prevention.Methods:Data from the Chinese Birth Defects Monitoring Network(CBDMN)during 2010–2018 were used to analyze the epidemiological pattern in the prevalence of 15 major birth defects and the trends over time.Results:In the period of 2010–2018,the top 10 most frequently-occurring birth defects in China included congenital heart diseases(CHDs),polydactyly,cleft lip with or without palate(CL/P),club foot,syndactyly,hydrocephalus,hypospadias,limb reduction defects(LRD),anotia/microtia,and anorectal atresia/stenosis.There was a decrease in the prevalence of neural tube defects,CL/P,hydrocephalus,LRD,gastroschisis,and omphalocele,but there were increases in the prevalence of CHDs,cleft palate,hypospadias,club foot,polydactyly,and syndactyly.The prevalence of most birth defects varied significantly by maternal age,area types(urban/rural),and geographic regions.Conclusions and Implications for Public Health Practice:The findings indicated that the comprehensive prevention of birth defects should focus on these selected birth defects,elderly pregnant women,rural areas,and western regions. 展开更多
关键词 PREVENTION defects BIRTH
原文传递
Genomic imprinting biomarkers for cervical cancer risk stratification
6
作者 Xue Xiao Wei Wang +22 位作者 Peng Bai Ying Chen Zhengwen Qin Tong Cheng Xing Li John P.Pineda Panying Shi Xiaonan Wang Jianhong Wang Lian Xu Xuemei Gao Huixian Zheng Lulu Yang Wenyi Lin Wenbin Huang Rulong Shen Changjun Yue Huixiong Xu Felipe Batalini Yang liu Ning Zhou Yaoyao Zhang hanmin liu 《Cancer Communications》 2024年第12期1385-1390,共6页
Cervical cancer remains a significant global public health issue due to its high incidence and mortality.Current clinical guidelines recommend screening for high-risk human papillomavirus(hrHPV)-DNA alongside a Thinpr... Cervical cancer remains a significant global public health issue due to its high incidence and mortality.Current clinical guidelines recommend screening for high-risk human papillomavirus(hrHPV)-DNA alongside a Thinprep cytologic test(TCT)before further medical evaluation[1]. 展开更多
关键词 CANCER MORTALITY CERVICAL
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部